HZNP Horizon Pharma plc

26.76
-0.08  -0%
Previous Close 26.84
Open 26.75
Price To Book 4.66
Market Cap 4935443457
Shares 184,433,612
Volume 675,884
Short Ratio
Av. Daily Volume 2,155,167

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released December 8, 2016 - primary endpoint not met.
ACTIMMUNE
Friedreich's Ataxia (FA)
Phase 3 data released February 28, 2019 - endpoints met.
Teprotumumab
Thyroid Eye Disease (TED)
Phase 2 trial initiation announced September 27, 2018.
Krystexxa with Methotrexate
Gout

Latest News

  1. Which Pharmaceutical Stocks Are Outperforming All Other Stocks?
  2. Edited Transcript of HZNP earnings conference call or presentation 27-Feb-19 1:00pm GMT
  3. Horizon Pharma plc Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy
  4. Horizon Pharma plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
  5. Why This Top-Ranked Pharma Grabbed An Upgrade Despite DOJ Probe
  6. Horizon Pharma plc Announces Pricing of Public Offering of Ordinary Shares
  7. No. 1 Pharma Stock Dives As DOJ Investigates Potential Kickbacks
  8. Dow Jones Futures: Nio, Qutoutiao IPOs Lead 5 Key Stocks Moving
  9. The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split
  10. Analysis: Positioning to Benefit within The Goodyear Tire & Rubber, Cars, Tutor Perini, CVS Health, VMware, and Horizon Pharma Public — Research Highlights Growth, Revenue, and Consolidated Results
  11. Horizon Pharma plc Announces Proposed Public Offering of Ordinary Shares
  12. 3 High-Growth Stocks That Are Just Getting Started
  13. Celebrating the Greatness of Individual Traders
  14. Horizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  15. Company News For Mar 1, 2019
  16. The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis
  17. Why These Pharma ETFs Rallied on Thursday
  18. 3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation
  19. Why Monster Beverage, Horizon Pharma, and Guardant Health Jumped Today
  20. No. 1 Pharma Skyrockets To 4-Year High On Bullish Results In Eye Disease